MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 181 filers reported holding MERIDIAN BIOSCIENCE INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $291,000 | -36.0% | 14,261 | -46.7% | 0.02% | -26.7% |
| Q3 2020 | $455,000 | +129.8% | 26,768 | +151.5% | 0.03% | +500.0% |
| Q2 2015 | $198,000 | -41.2% | 10,643 | -39.7% | 0.01% | -37.5% |
| Q1 2015 | $337,000 | -17.0% | 17,660 | -23.0% | 0.01% | -27.3% |
| Q3 2014 | $406,000 | -65.9% | 22,933 | -58.1% | 0.01% | -62.1% |
| Q1 2014 | $1,192,000 | +64.0% | 54,708 | +78.0% | 0.03% | +45.0% |
| Q3 2013 | $727,000 | – | 30,736 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |